Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life

Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life

Background: Janus kinase inhibitors (JAKis) represent a new alternative to treat rheumatoid arthritis (RA). The objective of this study was to evaluate the effectiveness, tolerance profile, and maintenance of these treatments (tofacitinib and baricitinib) in real life. Methods: All patients in the r...

Full description

Bibliographic Details
Main Authors: Valentine Deprez, Laure Le Monnier, Jean-Marc Sobhy-Danial, Franck Grados, Isabelle Henry-Desailly, Sarah Salomon-Goëb, Thibault Rabin, Sanja Ristic, Mathurin Fumery, Patrice Fardellone, Vincent Goëb
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Clinical Medicine
Subjects:
rheumatoid arthritis
JAK inhibitors
baricitinib
tofacitinib
therapeutic maintenance
Online Access:https://www.mdpi.com/2077-0383/9/10/3319

Internet

https://www.mdpi.com/2077-0383/9/10/3319

Similar Items